Anthony Tumber

7.5k total citations · 1 hit paper
95 papers, 3.6k citations indexed

About

Anthony Tumber is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Anthony Tumber has authored 95 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 37 papers in Cancer Research and 11 papers in Biochemistry. Recurrent topics in Anthony Tumber's work include Epigenetics and DNA Methylation (39 papers), Cancer, Hypoxia, and Metabolism (34 papers) and Histone Deacetylase Inhibitors Research (24 papers). Anthony Tumber is often cited by papers focused on Epigenetics and DNA Methylation (39 papers), Cancer, Hypoxia, and Metabolism (34 papers) and Histone Deacetylase Inhibitors Research (24 papers). Anthony Tumber collaborates with scholars based in United Kingdom, United States and Japan. Anthony Tumber's co-authors include Christopher J. Schofield, Peter A. Hill, Murray C. Meikle, Udo Oppermann, Akane Kawamura, Lennart Brewitz, James W.A. Ritchie, Laura S. Collins, Maxwell Sehested and Paul E. Brennan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Anthony Tumber

94 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

2007 599 citations Anthony Tumber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Tumber United Kingdom	32	2.9k	676	584	340	267	95	3.6k
Philip L. Lorenzi United States	35	2.5k 0.9×	1.2k 1.8×	679 1.2×	144 0.4×	184 0.7×	109	3.6k
Min H. Kang United States	38	3.6k 1.3×	689 1.0×	1.7k 3.0×	188 0.6×	315 1.2×	140	5.2k
Hidenori Nakajima Japan	22	2.9k 1.0×	290 0.4×	589 1.0×	504 1.5×	136 0.5×	45	3.6k
Angelika M. Burger United States	37	2.7k 1.0×	684 1.0×	981 1.7×	491 1.4×	184 0.7×	81	4.1k
Saverio Tardito Italy	24	1.6k 0.5×	1.0k 1.5×	916 1.6×	413 1.2×	181 0.7×	37	3.1k
Mårten Fryknäs Sweden	27	1.7k 0.6×	478 0.7×	799 1.4×	150 0.4×	214 0.8×	77	2.7k
Ker Yu United States	36	3.3k 1.1×	570 0.8×	631 1.1×	800 2.4×	169 0.6×	84	4.5k
Moulay A. Alaoui‐Jamali Canada	42	3.1k 1.1×	792 1.2×	1.3k 2.2×	332 1.0×	89 0.3×	138	4.8k
Hong Wu China	28	2.2k 0.8×	173 0.3×	526 0.9×	254 0.7×	91 0.3×	61	2.9k
Pádraig D’Arcy Sweden	26	2.3k 0.8×	422 0.6×	951 1.6×	128 0.4×	211 0.8×	61	2.8k

Countries citing papers authored by Anthony Tumber

Since Specialization

Citations

This map shows the geographic impact of Anthony Tumber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Tumber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Tumber more than expected).

Fields of papers citing papers by Anthony Tumber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Tumber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Tumber. The network helps show where Anthony Tumber may publish in the future.

Co-authorship network of co-authors of Anthony Tumber

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Tumber. A scholar is included among the top collaborators of Anthony Tumber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Tumber. Anthony Tumber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tumber, Anthony, et al.. (2025). Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase. Journal of Medicinal Chemistry. 68(9). 9777–9798.

2.

Salah, E., et al.. (2025). Biochemical investigations using mass spectrometry to monitor JMJD6-catalysed hydroxylation of multi-lysine containing bromodomain-derived substrates. RSC Chemical Biology. 6(4). 642–656. 1 indexed citations

3.

Salah, E., Bhaskar Bhushan, A. Szykowska, et al.. (2024). Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate. Journal of Medicinal Chemistry. 67(6). 4525–4540. 4 indexed citations

4.

Miura, Takashi, Tika R. Malla, Lennart Brewitz, et al.. (2024). Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease. Bulletin of the Chemical Society of Japan. 97(5). uoae018–uoae018. 12 indexed citations

5.

Salah, E., et al.. (2024). Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and Enarodustat. ChemMedChem. 19(24). e202400504–e202400504. 1 indexed citations

6.

Tumber, Anthony, et al.. (2023). Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5. RSC Chemical Biology. 4(6). 399–413. 12 indexed citations

7.

Brewitz, Lennart, Yu Nakashima, E. Salah, et al.. (2023). 5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5. Journal of Medicinal Chemistry. 66(15). 10849–10865. 7 indexed citations

8.

Wu, Yue, E. Salah, Yu Nakashima, et al.. (2023). Structure-guided optimisation of N-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α. Chemical Science. 14(43). 12098–12120. 8 indexed citations

9.

Brewitz, Lennart, Jos J. A. G. Kamps, Petra Lukacik, et al.. (2022). Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease. ChemMedChem. 17(9). e202200016–e202200016. 20 indexed citations

10.

Cockman, Matthew E., Yoichiro Sugimoto, Norma Masson, et al.. (2022). Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6. Proceedings of the National Academy of Sciences. 119(32). e2201483119–e2201483119. 23 indexed citations

11.

Malla, Tika R., Anthony Tumber, Lennart Brewitz, et al.. (2021). Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease. ChemMedChem. 17(4). e202100582–e202100582. 23 indexed citations

12.

Pfeffer, Inga, Lennart Brewitz, Rasheduzzaman Chowdhury, et al.. (2021). Human Oxygenase Variants Employing a Single Protein Fe^II Ligand Are Catalytically Active. Angewandte Chemie. 133(26). 14778–14784. 1 indexed citations

13.

Nakashima, Yu, Lennart Brewitz, Anthony Tumber, E. Salah, & Christopher J. Schofield. (2021). 2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases. Nature Communications. 12(1). 6478–6478. 23 indexed citations

14.

Malla, Tika R., Anthony Tumber, Tobias John, et al.. (2021). Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M^pro inhibitors. Chemical Communications. 57(12). 1430–1433. 32 indexed citations

15.

Pfeffer, Inga, Lennart Brewitz, Rasheduzzaman Chowdhury, et al.. (2021). Human Oxygenase Variants Employing a Single Protein Fe^II Ligand Are Catalytically Active. Angewandte Chemie International Edition. 60(26). 14657–14663. 15 indexed citations

16.

Cottone, Lucia, Adam P. Cribbs, Garima Khandelwal, et al.. (2020). Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death. Cancer Research. 80(20). 4540–4551. 35 indexed citations

17.

Brewitz, Lennart, Anthony Tumber, Armin Thalhammer, et al.. (2020). Synthesis of Novel Pyridine‐Carboxylates as Small‐Molecule Inhibitors of Human Aspartate/Asparagine‐β‐Hydroxylase. ChemMedChem. 15(13). 1139–1149. 18 indexed citations

18.

Abboud, Martine I., Rasheduzzaman Chowdhury, Anthony Tumber, et al.. (2020). Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from Dictyostelium discoideum and Toxoplasma gondii. Journal of Biological Chemistry. 295(49). 16545–16561. 13 indexed citations

19.

Fey, Kerstin, Christian R. Wick, Martine I. Abboud, et al.. (2018). A Fluorescent Benzo[g]isoquinoline‐Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging. ChemMedChem. 14(1). 94–99. 2 indexed citations

20.

Wolstenhulme, Stephen, Anthony Tumber, Stephanie B. Hatch, et al.. (2017). Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7. Angewandte Chemie. 129(49). 15761–15765. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact